The use of anchored agonists of phagocytic receptors for cancer immunotherapy: B16-F10 murine melanoma model.

The use of anchored agonists of phagocytic receptors for cancer immunotherapy: B16-F10 murine melanoma model.

The application of the phagocytic receptor agonists in cancer immunotherapy was studied. Agonists (laminarin, molecules with terminal mannose, N-Formyl-methioninyl-leucyl-phenylalanine) were firmly anchored to the tumor cell surface. When particular agonists of phagocytic receptors were used togethe...

Full description

Bibliographic Details
Main Authors: Tereza Janotová, Marie Jalovecká, Marie Auerová, Ivana Švecová, Pavlína Bruzlová, Veronika Maierová, Zuzana Kumžáková, Štěpánka Cunátová, Zuzana Vlčková, Veronika Caisová, Petra Rozsypalová, Katarína Lukáčová, Nikol Vácová, Markéta Wachtlová, Jiří Salát, Jaroslava Lieskovská, Jan Kopecký, Jan Ženka
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3890306?pdf=render

Internet

http://europepmc.org/articles/PMC3890306?pdf=render

Similar Items